Health Condition 1: L209- Atopic dermatitis, unspecified
Conditions
Interventions
Intervention1: Modified Vijaya Oil: Topical application at room temperature twice a day in the morning and evening.
Control Intervention1: NIL: NIL
Sponsors
Bombay Hemp Company
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or Female Subjects in the age group of 12 to 75 years (both inclusive). 2. Subjects with no medical history of significant diseases. 3. Subjects having vital signs that are within clinically acceptable limits. 4. Subjects of female gender who are not pregnant as per beta Human Chorionic Gonadotropin (HCG) test report. 5. Subjects with no significant medical complaints. 6. Subjects with no significant known allergies. 7. Subjects willing to follow the procedures as per the study protocol and voluntarily sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Subjects who have underwent any laser dermatological procedure, 4 weeks prior to screening in this study. 2. Known cases of Severe/Chronic hepatic or renal disease. 3. Known case of any active malignancy. 4. Subjects having known chronic, contagious infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV. 5. Subjects participating currently or 1 month prior to recruitment in any other clinical study. 6. Known hypersensitivity to any of the ingredients used in study drug. 7. Pregnant and Lactating females.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of modified Vijaya oil in patients suffering from eczema in terms of changes in EASI Score before and after intervention i.e between Day 0 and Day 30.Timepoint: To evaluate the efficacy of modified Vijaya oil in patients suffering from eczema in terms of changes in EASI Score before and after intervention i.e between Day 0 and Day 30. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess the changes in SCORAD before and after intervention, i.e between Day 0 and Day 30. 2. To assess the Changes in Pruritus Visual Analogue Scale (VAS) before and after intervention. 3. To assess the change in area of the lesion on body surface before and after intervention. 4. To assess the changes in SIGA Score before and after intervention. 5. To assess the Photographic changes in eczematous lesions before and after intervention.Timepoint: 1. To assess the changes in SCORAD before and after intervention, i.e between Day 0 and Day 30. 2. To assess the Changes in Pruritus Visual Analogue Scale (VAS) before and after intervention. 3. To assess the change in area of the lesion on body surface before and after intervention. 4. To assess the changes in SIGA Score before and after intervention. 5. To assess the Photographic changes in eczematous lesions before and after intervention. | — |
Countries
India
Contacts
Public ContactVedhika Manoj
National Institute Of Ayurveda, Jaipur
Outcome results
None listed